ES2158938T3 - Derivados de aminoquinazolina que tienen actividad alfa-antagonistas. - Google Patents
Derivados de aminoquinazolina que tienen actividad alfa-antagonistas.Info
- Publication number
- ES2158938T3 ES2158938T3 ES95911342T ES95911342T ES2158938T3 ES 2158938 T3 ES2158938 T3 ES 2158938T3 ES 95911342 T ES95911342 T ES 95911342T ES 95911342 T ES95911342 T ES 95911342T ES 2158938 T3 ES2158938 T3 ES 2158938T3
- Authority
- ES
- Spain
- Prior art keywords
- alfa
- antagonist activity
- aminoquinazoline derivatives
- compounds
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005557 antagonist Substances 0.000 title 1
- CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical class C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000001800 adrenalinergic effect Effects 0.000 abstract 1
- 208000037849 arterial hypertension Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000013403 hyperactivity Diseases 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Abstract
NUEVOS DERIVADOS DE QUINAZOLINIL-AMINO UTILES COMO BLOQUEADORES ADRENORECEPTORES {AL}{SUB,1}. ESTOS COMPUESTOS PUEDEN SER USADOS COMO AGENTES TERAPEUTICOS PARA TRATAR AFECCIONES Y ENFERMEDADES RELACIONADAS CON LA HIPERACTIVIDAD DEL SISTEMA ADRENERGICO {AL}, COMO, POR EJEMPLO, HIPERTENSION ARTERIAL, HIPERBLASIA BENIGNA DE PROSTATA (HBP), PRESION INTRAOCULAR ALTA E HIPERCOLESTEROLEMIA. TAMBIEN SE DESCRIBEN LOS PROCESOS PARA LA PREPARACION DE DICHOS COMPUESTOS DE ARRIBA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI940506A IT1270993B (it) | 1994-03-18 | 1994-03-18 | Derivati chinzolilamminici attivi come alfa-antagonisti |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2158938T3 true ES2158938T3 (es) | 2001-09-16 |
Family
ID=11368249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95911342T Expired - Lifetime ES2158938T3 (es) | 1994-03-18 | 1995-03-17 | Derivados de aminoquinazolina que tienen actividad alfa-antagonistas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5798362A (es) |
EP (1) | EP0750614B1 (es) |
JP (1) | JP3683911B2 (es) |
AT (1) | ATE201400T1 (es) |
AU (1) | AU1894895A (es) |
DE (1) | DE69521037T2 (es) |
DK (1) | DK0750614T3 (es) |
ES (1) | ES2158938T3 (es) |
GR (1) | GR3036443T3 (es) |
IL (1) | IL113024A (es) |
IT (1) | IT1270993B (es) |
PT (1) | PT750614E (es) |
TW (1) | TW416951B (es) |
WO (1) | WO1995025726A1 (es) |
ZA (1) | ZA952208B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747490A (en) * | 1995-09-29 | 1998-05-05 | Merck & Co., Inc. | Alpha 1b adrenergic receptor antagonists |
AU7692896A (en) * | 1995-12-01 | 1997-06-27 | Novartis Ag | Quinazolin-2,4-diazirines as NPY receptor antagonist |
IT1286302B1 (it) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso |
GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
GB9711650D0 (en) * | 1997-06-05 | 1997-07-30 | Pfizer Ltd | Compounds useful in therapy |
US7186726B2 (en) * | 1998-06-30 | 2007-03-06 | Neuromed Pharmaceuticals Ltd. | Preferentially substituted calcium channel blockers |
US6355641B1 (en) | 1999-03-17 | 2002-03-12 | Syntex (U.S.A.) Llc | Oxazolone derivatives and uses thereof |
IT1312310B1 (it) | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
US20040072839A1 (en) * | 2002-06-14 | 2004-04-15 | Amedeo Leonardi | 1-Phenylalkylpiperazines |
US20040058962A1 (en) * | 2002-06-14 | 2004-03-25 | Amedeo Leonardi | Phenylalkylamines and pyridylalkylamines |
US7071197B2 (en) | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
US7820673B2 (en) * | 2003-12-17 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same, and use |
US20060264442A1 (en) * | 2005-05-18 | 2006-11-23 | Allergan, Inc. | Methods for the treatment of ocular and neurodegenerative conditions in a mammal |
ES2584702T3 (es) | 2012-06-20 | 2016-09-28 | Novartis Ag | Moduladores de ruta del complemento y usos de los mismos |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE925468C (de) * | 1941-08-13 | 1955-03-21 | Hoechst Ag | Verfahren zur Herstellung von ª†, ª†-Diaryl-propyl-aminen |
GB679676A (en) * | 1950-04-03 | 1952-09-24 | Dow Chemical Co | Improved method for the production of salts of aromatic-oxy-aliphatic carboxylic acids |
US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
DE2143730A1 (de) * | 1971-09-01 | 1973-03-08 | Byk Gulden Lomberg Chem Fab | Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel |
US4044136A (en) * | 1972-09-09 | 1977-08-23 | Pfizer Inc. | Aminoquinazoline therapeutic agents |
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4062844A (en) * | 1976-09-20 | 1977-12-13 | Pfizer Inc. | Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines |
FR2389614A1 (en) * | 1977-05-05 | 1978-12-01 | Synthelabo | Antihypertensive 2,4-di:amino-quinazoline(s) - prepd. from a 2-halo-4-amino-quinazoline and a secondary amine |
US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
GB2068961B (en) * | 1980-02-13 | 1983-11-30 | Sankyo Co | Quinazoline derivatives |
CS236097B1 (en) * | 1983-06-01 | 1985-05-15 | Jan Koenig | Acylderivatives of 2-piperazinochinazoline and method of their preparation |
AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
US5110927A (en) * | 1987-12-31 | 1992-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Prazosin analog with increased selectivity and duration of action |
-
1994
- 1994-03-18 IT ITMI940506A patent/IT1270993B/it active IP Right Grant
-
1995
- 1995-03-17 DK DK95911342T patent/DK0750614T3/da active
- 1995-03-17 AU AU18948/95A patent/AU1894895A/en not_active Abandoned
- 1995-03-17 PT PT95911342T patent/PT750614E/pt unknown
- 1995-03-17 ES ES95911342T patent/ES2158938T3/es not_active Expired - Lifetime
- 1995-03-17 IL IL11302495A patent/IL113024A/xx not_active IP Right Cessation
- 1995-03-17 EP EP95911342A patent/EP0750614B1/en not_active Expired - Lifetime
- 1995-03-17 ZA ZA952208A patent/ZA952208B/xx unknown
- 1995-03-17 US US08/716,160 patent/US5798362A/en not_active Expired - Fee Related
- 1995-03-17 JP JP52437095A patent/JP3683911B2/ja not_active Expired - Fee Related
- 1995-03-17 DE DE69521037T patent/DE69521037T2/de not_active Expired - Fee Related
- 1995-03-17 WO PCT/EP1995/001001 patent/WO1995025726A1/en active IP Right Grant
- 1995-03-17 AT AT95911342T patent/ATE201400T1/de not_active IP Right Cessation
- 1995-05-23 TW TW084105132A patent/TW416951B/zh not_active IP Right Cessation
-
2001
- 2001-08-23 GR GR20010401292T patent/GR3036443T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE201400T1 (de) | 2001-06-15 |
DK0750614T3 (da) | 2001-09-10 |
DE69521037T2 (de) | 2001-10-25 |
GR3036443T3 (en) | 2001-11-30 |
WO1995025726A1 (en) | 1995-09-28 |
EP0750614B1 (en) | 2001-05-23 |
PT750614E (pt) | 2001-10-31 |
JPH09511238A (ja) | 1997-11-11 |
IT1270993B (it) | 1997-05-26 |
IL113024A0 (en) | 1995-06-29 |
ITMI940506A1 (it) | 1995-09-18 |
US5798362A (en) | 1998-08-25 |
ZA952208B (en) | 1995-12-28 |
DE69521037D1 (de) | 2001-06-28 |
IL113024A (en) | 2000-07-26 |
JP3683911B2 (ja) | 2005-08-17 |
ITMI940506A0 (it) | 1994-03-18 |
EP0750614A1 (en) | 1997-01-02 |
AU1894895A (en) | 1995-10-09 |
TW416951B (en) | 2001-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2158938T3 (es) | Derivados de aminoquinazolina que tienen actividad alfa-antagonistas. | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
EA200200768A1 (ru) | Соединения индазола, фармацевтические композиции и методы модуляции или ингибирования клеточной пролиферации | |
ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
EA200001223A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
BR9812122A (pt) | Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata | |
DE3774918D1 (de) | Cancerostatisches mittel. | |
DE69521620T2 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
DE59611341D1 (de) | Verwendung von saccharid-konjugaten | |
EA200000759A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
ATE181913T1 (de) | 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)- benzopyran für die behandlung von proliferativer erkrankungen | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
MY121548A (en) | Compounds and methods for the treatment of cancer | |
UY23909A1 (es) | Procedimiento para la preparacion de 6- derivados sustitutivos del acido micofenolico | |
BRPI0413574A (pt) | aplicação de polipeptìdeos da famìlia cupredoxina na terapia do cáncer | |
ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
ATE83376T1 (de) | Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten. | |
BR0012921A (pt) | Compostos calcilìticos | |
DE69837622D1 (de) | Taurinderivate verwendbar in der behandlung von netzhauterkrankungen | |
EA199900363A1 (ru) | Новые производные пентаэритрита, их получение и применение, а также промежуточные продукты для их синтеза | |
ES2153584T3 (es) | Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos. | |
CO4340732A1 (es) | 4-amino-derivados del acido micofenolico 5-substituido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 750614 Country of ref document: ES |